Leukocyte adhesion deficiency II: therapy and genetic defect.
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates. Hypofucosylated structures include ligands for the selectin family of adhesion molecules. This results in a leukocyte adhesion defect causing an immunodeficiency. In...
المؤلفون الرئيسيون: | Wild, M, Lühn, K, Marquardt, T, Vestweber, D |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2002
|
مواد مشابهة
-
The role of fucosylation in leukocyte adhesion deficiency II.
حسب: Vestweber, D, وآخرون
منشور في: (2004) -
Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter.
حسب: Helmus, Y, وآخرون
منشور في: (2006) -
The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter.
حسب: Lühn, K, وآخرون
منشور في: (2001) -
Correction of leukocyte adhesion deficiency type II with oral fucose.
حسب: Marquardt, T, وآخرون
منشور في: (1999) -
Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism.
حسب: Marquardt, T, وآخرون
منشور في: (1999)